Quick Answer
Ocugen, Inc. reported Total Revenue of $4.41 million for the year ending 2025.
- Ocugen, Inc. showed an increase of +8.8% in Total Revenue from 2024 to 2025.
- This data is from Ocugen, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2017: $0.00 | Q3 2017: $0.00 | Q1 2018: $0.00 | Q2 2018: $0.00 | Q3 2018: $0.00 | Q1 2019: $0.00 | Q2 2019: $0.00 | Q3 2019: $0.00 | Q2 2020: $43.0 thousand | Q3 2020: $0.00 | Q2 2021: $0.00 | Q3 2021: $0.00 | Q1 2022: $500.0 thousand | Q2 2022: $643.0 thousand | Q3 2022: $466.0 thousand | Q1 2023: $443.0 thousand | Q2 2023: $485.0 thousand | Q3 2023: $3.70 million | Q1 2024: $1.01 million | Q2 2024: $1.14 million | Q3 2024: $1.14 million | Q1 2025: $1.48 million | Q2 2025: $1.37 million | Q3 2025: $1.75 million.
- Historical annual values: Fiscal year 2025: $4.41 million | Fiscal year 2024: $4.06 million | Fiscal year 2023: $6.04 million | Fiscal year 2022: $2.49 million | Fiscal year 2021: $0.00 | Fiscal year 2020: $43.0 thousand | Fiscal year 2019: $0.00 | Fiscal year 2018: $0.00 | Fiscal year 2017: $0.00.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: